Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1983-09-16
1985-03-12
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
A61K 3133, A61K 3144
Patent
active
045044767
ABSTRACT:
A method of potentiating the effect of a dihydropyridine derivative, such as nimodipine or nifedipine, by administering d-cis-diltiazem in an amount sufficient to inhibit calcium influx but insufficient to cause substantial decrease in contractility, and administering a dihydropyridine derivative in a submicromolar amount less than the dosage normally required for pharmacological effectiveness. A calcium channel blocking composition comprises a synergistic combination of d-cis-diltiazem and a dihydropyridine derivative.
REFERENCES:
patent: 4264497 (1981-04-01), Ohno et al.
Chem. Abst. 99:3563(r), (1983)-Andersson et al.
Chem. Abst. 99:64,033(q), (1983)-Glossman et al.
Chem. Abst. 99:115,596(k), (1983)-DePover et al.
Chem. Abst. 99:151,887(q), (1983)-Van Meel et al.
Chem. Abst. 99:205,834(r), (1983)-Van Meel et al.
Chem. Abst. 100:18032(e), (1984)-Conn et al.
Chem. Abst. 100:29610(t), (1984)-Spedding.
de Pover Alain
Grupp Gunter
Grupp Ingrid L.
Schwartz Arnold
LandOfFree
Method of administering calcium channel blocking agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of administering calcium channel blocking agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of administering calcium channel blocking agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-707584